Rebstock Elizabeth Rebstock

Dr. Rebstock Elizabeth Rebstock

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Sensors
Verified
Journal Article
Open access
PDF file
SLSamuel Thomas Lauman
Samuel Thomas Lauman
LPLindsey J. Patton
Lindsey J. Patton
PCPeng Robert Chen
Peng Robert Chen
SRShreya Ravi
Shreya Ravi
SKStephen MD Kimatian
Stephen MD Kimatian
RRRebstock Elizabeth Rebstock
Rebstock Elizabeth Rebstock
Accurate range of motion (ROM) assessment is essential for evaluating musculoskeletal function and guiding rehabilitation, particularly in pediatric populations. Traditional methods, such as optical motion capture and handheld goniometry, are often limited by cost, accessibility, and inter-rater variability. This study evaluated the feasibility and accuracy of the Microsoft Azure Kinect-powered Monitored Augmented Rehabilitation System (MARS) compared to Kinovea. Sixty-five pediatric participants (ages 5–18) performed standardized shoulder and elbow movements in the frontal and sagittal planes. ROM data were recorded using MARS and compared to Kinovea. Measurement reliability was evaluated using intraclass correlation coefficients (ICC3k), and accuracy was evaluated using root mean squared error (RMSE) analysis. MARS demonstrated excellent reliability with an average ICC3k of 0.993 and met the predefined accuracy threshold (RMSE ≤ 8°) for most movements, with the exception of sagittal elbow flexion. These findings suggest that MARS is a reliable, accurate, and cost-effective alternative for clinical ROM assessment, offering a markerless solution that enhances measurement precision and accessibility in pediatric rehabilitation. Future studies should enhance accuracy in sagittal plane movements and further validate MARS against gold-standard systems.

11 February 2021 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
IMIngrid Moreno‐Duarte
Ingrid Moreno‐Duarte
AEAmanda S. Evans
Amanda S. Evans
AAAdam C. Alder
Adam C. Alder
MVMadeline C. Vernon
Madeline C. Vernon
PSPeter Szmuk
Peter Szmuk
RRRebstock Elizabeth Rebstock
Rebstock Elizabeth Rebstock

30 January 2026 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
SLSamuel Thomas Lauman
Samuel Thomas Lauman
SRShreya Ravi
Shreya Ravi
KCKara Chaplin
Kara Chaplin
MRMegan Roberts
Megan Roberts
DLDeanna Lusty
Deanna Lusty
RRRebstock Elizabeth Rebstock
Rebstock Elizabeth Rebstock
Cerebral arteriovenous malformations (AVMs) are congenital vascular abnormalities that can lead to neurological impairments following rupture. This proof-of-concept case report examines the integration of the Monitored Augmented Rehabilitation System (MARS), an immersive virtual gaming platform, into a multidisciplinary rehabilitation program for a 12-year-old female recovering from a ruptured AVM. MARS was used as an adjunct modality alongside conventional interventions over a 4-week period to target functional outcomes as assessed by the Neurocom Balance Manager ® . Quantitative results demonstrated targeted functional gains: Directional Control during the Limits of Stability test increased from 66% to 73%, toes-up Adaptation Test scores improved from 104.2 to 116.2, and toes-down scores from 115.6 to 119.0. Clinically observed increases in engagement, motivation, and adherence were noted during therapy sessions. This report underscores the feasibility and clinical potential of MARS as a complementary tool for enhancing motor learning and functional outcomes in pediatric neurorehabilitation. Future research should focus on larger sample sizes and extended intervention periods to validate the efficacy of MARS in improving long-term recovery outcomes.

5 November 2025 in Journal of Burn Care & Research
Verified
Journal Article
Open access
CLChristopher R LaChapelle
Christopher R LaChapelle
AAAditee Ambardekar
Aditee Ambardekar
JRJenny Ringqvist
Jenny Ringqvist
ABAiden Berry
Aiden Berry
PNPaul Nakonezny
Paul Nakonezny
RRRebstock Elizabeth Rebstock
Rebstock Elizabeth Rebstock
Postoperative pain management is a significant challenge in patients undergoing burn excision. Pharmacologic pain management strategies include both opioid and non-opioid medications. Given the national overuse of opioids and the associated negative effects, it is prudent and essential to find ways to manage pain with fewer or no opioids. We hypothesize that intraoperative administration of intravenous methadone reduces total morphine milligram equivalents per weight used in the 36 h following surgery. This is a retrospective, single-center cohort study of adult burn patients who underwent a first excision of full thickness burn between January 2019 and January 2021. One group received intraoperative intravenous methadone while the non-exposure group did not. The primary outcome was total morphine milligram equivalents per weight utilized in the 36 h following surgery. Secondary outcomes included average pain scores in the post-anesthesia care unit and for 36 h postoperatively, as well as discharge opioid prescriptions. The methadone group contained 104 subjects, and the non-exposure group contained 119 subjects. Poisson regression, with adjustment for covariates, showed that the methadone group required fewer 36-h postoperative opioids (IRR = 0.89, P = .447) and were discharged with fewer opioid prescriptions (IRR = 0.86, P = .363) independent of the age and %TBSA differences. Post-anesthesia care unit pain scores were lower in the methadone group (IRR = 0.91, P = .350), as were 36-h postoperative pain scores (IRR = 0.92, P = .310). These trends toward improved pain control and reduced opioid requirements in patients receiving intraoperative, intravenous methadone did not reach statistical significance. Prospective, adequately powered randomized studies are needed to advance these findings.